HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mireia Pelegrin Selected Research

Immunotherapy

2/2013Control of regulatory T cells is necessary for vaccine-like effects of antiviral immunotherapy by monoclonal antibodies.
6/2010A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy.
2/2008Endogenous cytotoxic T-cell response contributes to the long-term antiretroviral protection induced by a short period of antibody-based immunotherapy of neonatally infected mice.
3/2004Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mireia Pelegrin Research Topics

Disease

8Infections
12/2021 - 10/2003
6Virus Diseases (Viral Diseases)
02/2021 - 03/2004
5Neoplasms (Cancer)
12/2019 - 03/2004
2Persistent Infection
06/2010 - 02/2008
2Viremia
10/2006 - 02/2002
2Autoimmune Diseases (Autoimmune Disease)
09/2004 - 03/2004
1Communicable Diseases (Infectious Diseases)
12/2019
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2014
1Disease Progression
10/2010
1Leukemia
06/2010
1Chronic Disease (Chronic Diseases)
09/2004

Drug/Important Bio-Agent (IBA)

8Monoclonal AntibodiesIBA
02/2021 - 03/2004
5Antiviral Agents (Antivirals)IBA
10/2010 - 10/2003
2AntibodiesIBA
12/2019 - 10/2003
2DNA (Deoxyribonucleic Acid)IBA
06/2014 - 02/2002
1ChemokinesIBA
12/2021
1CytokinesIBA
12/2021
1Broadly Neutralizing AntibodiesIBA
01/2019
1Immunoglobulin G (IgG)IBA
02/2013
1VaccinesIBA
02/2013
1difluprednateFDA Link
10/2010
1Immunoglobulin M (IgM)IBA
10/2010
1Immunoglobulins (Immunoglobulin)IBA
10/2006

Therapy/Procedure

4Immunotherapy
02/2013 - 03/2004
2Therapeutics
12/2021 - 09/2004
1Secondary Prevention
05/2005